ArticlePharmaceutics2023

Favorable Effect of Pemafibrate on Insulin Resistance and β-Cell Function in Subjects with Type 2 Diabetes and Hypertriglyceridemia: A Subanalysis of the PARM-T2D Study.

Hiroshi Nomoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.